Variable | Univariate logistic regression | Multivariate logistic regression | ||
---|---|---|---|---|
OR (95%CI) | P* | OR (95%CI) | P | |
Age, years | 1.008 (0.954–1.065) | 0.774 |  |  |
Sex | Â | 0.955 | Â | Â |
  Male | Reference |  |  |  |
  Female | 0.965 (0.282–3.302) |  |  |  |
Radiomics score (per 0.1 increase) | 2.172 (0.476–9.916) |  < 0.001* | 3.388 (0.538–21.334) |  < 0.001 |
DBRN, months | 0.992 (0.983–1.000) | 0.050* | 1.020 (1.001–1.040) | 0.034 |
DBRM, months | 0.997 (0.981–1.012) | 0.664 |  |  |
DBNM, months | 0.992 (0.958–1.028) | 0.674 |  |  |
AST, U/L | 1.029 (0.939–1.128) | 0.543 |  |  |
ALT, U/L | 0.989 (0.942–1.038) | 0.655 |  |  |
Hs-CRP, mg/L | 0.999 (0.978–1.021) | 0.947 |  |  |
Dmax of the GTVnx,Gy | 1.130 (0.910–1.404) | 0.269 |  |  |
Dmax of the GTVnd,Gy | 1.082 (0.947–1.237) | 0.246 |  |  |
Dmax of the temporal lobe, Gy | 0.982 (0.827–1.167) | 0.838 |  |  |
Radiotherapy methods | Â | 0.481 | Â | Â |
  Conventional radiotherapy | Reference |  |  |  |
  IMRT | 0.545 (0.101–2.944) |  |  |  |
MOCA | Â | 0.048* | Â | Â |
  < 26 | Reference |  |  |  |
  ≥ 26 | 0.357 (0.129–0.992) |  |  |  |
LENT-SOMA# | 0.917 (0.840–1.000) | 0.050* |  |  |
NPC stage | Â | 0.469 | Â | Â |
  II | Reference |  |  |  |
  III | 4.286 (0.438–41.954) | 0.211 |  |  |
  IV | 2.000 (0.191–20.898) | 0.563 |  |  |
  IVA | 3.125 (0.278–35.157) | 0.356 |  |  |
Steroid dose, mg/d | Â | 0.246 | Â | Â |
  80 | Reference |  |  |  |
  500 | 1.833 (0.658–5.107) |  |  |  |